These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10715103)

  • 1. Aminoglycoside-arginine conjugates that bind TAR RNA: synthesis, characterization, and antiviral activity.
    Litovchick A; Evdokimov AG; Lapidot A
    Biochemistry; 2000 Mar; 39(11):2838-52. PubMed ID: 10715103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.
    Cabrera C; Gutiérrez A; Blanco J; Barretina J; Litovchick A; Lapidot A; Evdokimov AG; Clotet B; Esté JA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):627-34. PubMed ID: 10791873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
    Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
    Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine-aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro.
    Litovchick A; Evdokimov AG; Lapidot A
    FEBS Lett; 1999 Feb; 445(1):73-9. PubMed ID: 10069377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
    Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
    J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
    Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
    Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
    Calnan BJ; Biancalana S; Hudson D; Frankel AD
    Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A; Vijayabaskar V; Litovchick A; Yu J; James TL
    FEBS Lett; 2004 Nov; 577(3):415-21. PubMed ID: 15556620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral activity of ethidium-arginine conjugates directed against the TAR RNA of HIV-1.
    Peytou V; Condom R; Patino N; Guedj R; Aubertin AM; Gelus N; Bailly C; Terreux R; Cabrol-Bass D
    J Med Chem; 1999 Oct; 42(20):4042-53. PubMed ID: 10514274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine-binding RNAs resembling TAR identified by in vitro selection.
    Tao J; Frankel AD
    Biochemistry; 1996 Feb; 35(7):2229-38. PubMed ID: 8652564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates.
    Eubank TD; Biswas R; Jovanovic M; Litovchick A; Lapidot A; Gopalan V
    FEBS Lett; 2002 Jan; 511(1-3):107-12. PubMed ID: 11821058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Hoechst 33258 to the TAR RNA of HIV-1. Recognition of a pyrimidine bulge-dependent structure.
    Dassonneville L; Hamy F; Colson P; Houssier C; Bailly C
    Nucleic Acids Res; 1997 Nov; 25(22):4487-92. PubMed ID: 9358156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
    Xie B; Calabro V; Wainberg MA; Frankel AD
    J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualizing tertiary folding of RNA and RNA-protein interactions by a tethered iron chelate: analysis ofHIV-1 Tat-TAR complex.
    Huq I; Tamilarasu N; Rana TM
    Nucleic Acids Res; 1999 Feb; 27(4):1084-93. PubMed ID: 9927743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific hydrolysis of HIV-1 TAR RNA element with the anti-TAR hammerhead ribozyme: structural and functional implications.
    Wyszko E; Barciszewska MZ; Bald R; Erdmann VA; Barciszewski J
    Int J Biol Macromol; 2001 Jun; 28(5):373-80. PubMed ID: 11325424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A; Parslow TG; Yuan YC; James TL
    J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
    Huq I; Rana TM
    Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.